UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051620
Receipt number R000058872
Scientific Title A Study on the Risk of Fractures in Patients with Chronic Kidney Disease (CKD) Using the Japanese Medical Information Database.
Date of disclosure of the study information 2023/07/15
Last modified on 2023/07/15 16:36:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Risk of Fractures in Patients with Chronic Kidney Disease (CKD) Using the Japanese Medical Information Database.

Acronym

A Study on the Risk of Fractures in Patients with Chronic Kidney Disease (CKD) Using the Japanese Medical Information Database.

Scientific Title

A Study on the Risk of Fractures in Patients with Chronic Kidney Disease (CKD) Using the Japanese Medical Information Database.

Scientific Title:Acronym

A Study on the Risk of Fractures in Patients with Chronic Kidney Disease (CKD) Using the Japanese Medical Information Database.

Region

Japan


Condition

Condition

Chronic Kidney Disease

Classification by specialty

Endocrinology and Metabolism Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to investigate the risk of bone fractures in patients with CKD in Japan using a receipts database.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Bone fracture

Key secondary outcomes

All-cause mortality
The implementation of bone density testing
Prescription of osteoporosis treatment drugs and medications related to bone metabolism


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who obtained eGFR measurements with a 2-point difference at intervals of 3 months or longer.
2) Age >=18 at index date

Key exclusion criteria

1) Patients with a confirmed diagnosis of cancer during the pre-index period.
2) Patients who underwent kidney transplantation or renal dialysis during the pre-index period.
3) Patients with a history of diseases related to decreased bone density or prescription history of osteoporosis drugs during the pre-index period.
4) Patients with a confirmed diagnosis of bone fractures during the pre-index period.
5) Patients who underwent blood sampling by a specific department (such as ICU/ER) on the index date.

Target sample size

100000


Research contact person

Name of lead principal investigator

1st name Tetsuya
Middle name
Last name Kimura

Organization

Daiichi Sankyo Co., Ltd.

Division name

Primary Medical Science Department

Zip code

103-0023

Address

3-5-1 Nihonbashi Honcho, Chuo-ku, Tokyo, Japan.

TEL

03-6225-1053

Email

kimura.tetsuya.d2@daiichisankyo.co.jp


Public contact

Name of contact person

1st name Ayumi
Middle name
Last name Shintani

Organization

Osaka Metropolitan University

Division name

Department of Medical Statistics

Zip code

545-8585

Address

1-3-4 Asahimachi, Abeno-ku, Osaka, Japan.

TEL

06-6645-3894

Homepage URL


Email

med-statacademy@ml.omu.ac.jp


Sponsor or person

Institute

Daiichi Sankyo Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Daiichi Sankyo Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation TOUKEIKAI Kitamachi Clinic ERB

Address

1-1-3,Kichijoji-kitamachi,Musashino-shi,Tokyo,180-0001,Japan

Tel

03-6779-8116

Email

chi-pr-ec-kitamachi@cmicgroup.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 04 Month 17 Day

Date of IRB


Anticipated trial start date

2023 Year 07 Month 24 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A Study on the Risk of Fractures in Patients with Chronic Kidney Disease (CKD) Using the Japanese Medical Information Database.


Management information

Registered date

2023 Year 07 Month 15 Day

Last modified on

2023 Year 07 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058872


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name